随海田,高汇迪,赵若颖,郭昱,苏锦锋,舒祥.高风险人群流感疫苗接种现况和免疫策略分析[J].Chinese journal of Epidemiology,2024,45(4):615-620 |
高风险人群流感疫苗接种现况和免疫策略分析 |
Analysis of influenza vaccination status and immunization strategy in high-risk population |
Received:July 18, 2023 |
DOI:10.3760/cma.j.cn112338-20230718-00016 |
KeyWord: 流感 临床风险人群 免疫策略 |
English Key Word: Influenza Clinical risk groups Immunization strategy |
FundProject: |
Author Name | Affiliation | E-mail | Sui Haitian | China National Biotec Group, Beijing 100024, China | | Gao Huidi | China National Biotec Group, Beijing 100024, China | | Zhao Ruoying | China National Biotec Group, Beijing 100024, China | | Guo Yu | China National Biotec Group, Beijing 100024, China | | Su Jinfeng | China National Biotec Group, Beijing 100024, China | | Shu Xiang | China National Biotec Group, Beijing 100024, China | shuxiang1@sinopharm.com |
|
Hits: 1668 |
Download times: 575 |
Abstract: |
流感是由流感病毒引起的一种呼吸道传染性疾病,严重疾病负担常见于高风险人群。接种流感疫苗是预防流感及其并发症的有效方法,尤其是对高风险人群。虽然已有部分国家将流感疫苗纳入国家免疫规划,但全球范围内高风险人群流感疫苗接种率仍然较低。目前,流感疫苗在我国仍属于自愿自费接种的非免疫规划疫苗,且全国各地流感疫苗免疫策略差异化明显,接种率与发达国家仍有差距。进一步优化我国流感疫苗全人群免疫策略,加强流感疫苗全人群免疫策略的宣传,降低我国流感的疾病负担,是目前迫切需要解决的问题。 |
English Abstract: |
Influenza is a contagious respiratory disease caused by influenza viruses, and the burden of severe disease is commonly seen in high risk populations. Influenza vaccination is an effective way to prevent influenza and its complications, especially for high risk populations. Although some countries have included influenza vaccine in their national immunization programs, influenza vaccination rates remain low globally in high risk populations. The influenza vaccine in China is still a non-immunization program vaccine that is voluntarily vaccinated at its own expense, and the influenza vaccine immunization strategy is different across the country. There is still a gap between the vaccination rate of the influenza vaccine and that of developed countries. It is an urgent problem to further optimize the whole population immunization strategy of influenza vaccine in China, strengthen the publicity of the whole population immunization strategy of influenza vaccine, and reduce the disease burden of influenza in China. |
View Fulltext
Html FullText
View/Add Comment Download reader |
Close |
|
|
|